• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    ImmunoGen, Inc. (IMGN)

    -NasdaqGS
    14.01 Down 0.26(1.82%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:14.27
    Open:14.31
    Bid:14.06 x 800
    Ask:18.00 x 400
    1y Target Est:11.72
    Beta:1.58
    Next Earnings Date:31-Jul-15IMGN Earnings announcement
    Day's Range:14.00 - 14.31
    52wk Range:5.34 - 15.88
    Volume:902,202
    Avg Vol (3m):2,018,760
    Market Cap:1.21B
    P/E (ttm):N/A
    EPS (ttm):-0.66
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    IMGNDown 1.82%1.21B
    PFEDown 0.95%205.48B
    RHHBYUp 0.09%N/A
    SGENDown 0.36%5.95B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):15.63
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :-0.71
    Quarterly EPS Est (Jun-15) :-0.35
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. It develops its products using its antibody-drug conjugates technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback